Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golidocitinib + Anthracycline in 1L Nodal TFH Cell Lymphoma
NCT07753642Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of golidocitinib in follicular T-cell lymphoma (FTCL), sponsored by Sun Yat-sen University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
golidocitinib
03
Conditions
follicular T-cell lymphoma (FTCL)
Beyond the preview
Go deeper on NCT07753642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07753642.